Follow The Filings

DOC Healthpeak Properties Inc.

Real Estate, filed as Healthpeak Properties, Inc. (COMMON), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.4%
  • $815K
  • 1 add

In 2026 Q3 Kentucky Trust added to Healthpeak Properties.

Who owns this now

Largest portfolio weights among holders, up to 0.4% (Kentucky Trust Co., Kentucky Trust). Not free-float ownership.

  1. Kentucky Trust Co. Add 0.41%

Who owns DOC

Sorted by value, long equity only, as of 2026 Q3.

History
Kentucky Trust Co., Kentucky Trust 0.41% Add +3.4% 40,793 $815K History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by DOC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All DOC insider trades
  • None no insider bought on the open market
  • $214K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Scott R Bohn CDO and Head of Lab
    Sale
    $214K 10,989 shares at $19.45 59% of stake
    Traded May 12 Filed May 13
    ↗

Also filed in the last 12 months, not counted as buying or selling: 23 stock grants and 18 share withholdings for taxes.

Congress

5 members of Congress traded DOC in the last three years: 3 buys and 4 sales. 3 members listed it in 2025 annual reports.

All Congress trades
  1. Alan Armstrong R-OK Buy $1K–$15K Mar 27 filed Jul 21
  2. Gilbert Ray Cisneros, Jr. D-CA-31 Sell $1K–$15K Feb 10 filed Mar 9
  3. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Jan 9 filed Feb 13
  4. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Aug 4, 2025 filed Sep 12, 2025
  5. Lisa C. McClain R-MI-9Spouse Buy $1K–$15K Jun 17, 2025 filed Aug 13, 2025
  6. Robert P. Bresnahan, Jr. R-PA-8 Sell $1K–$15K May 15, 2025 filed Jun 9, 2025

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 7.01 Filing Doc
10-K Filing Doc
8-K 2.02,7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 12 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $527.42M $568.48M $603.99M
Gross profit * -$374.64M -$506.39M —
Gross margin * -71.0% -89.1% —
Net income $306.01M $243.14M $71.35M
Net margin * 58.0% 42.8% 11.8%

Balance sheet

Metric FY2023 FY2024 FY2025
Total assets $15.7B $19.94B $20.34B
Total equity $6.35B $8.4B $7.5B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $0.956B $1.07B $1.25B
Cash from investing -$0.577B -$0.114B -$1.03B
Cash from financing -$337.3M -$941.42M $136.11M
Net change in cash $42.19M $15.28M $353.4M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.